CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 41 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $10,000 | +11.1% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $9,000 | -18.2% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $11,000 | -8.3% | 2,000 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $12,000 | -57.1% | 2,000 | -50.0% | 0.00% | 0.0% |
| Q2 2015 | $28,000 | -45.1% | 4,000 | -60.0% | 0.00% | -76.5% |
| Q2 2013 | $51,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |